Press release -
Chr. Hansen restructures its US organization
Full integration of Chr. Hansen US into the global organization and product strategies leads to the restructuring of the US organization, and a reduction of approximately 30 positions.
Following Chr. Hansen’s change from a functional to a divisional organization eight months ago, Chr. Hansen now takes the next step and fully aligns its North American organization to the rest of the global business. This also includes a full integration of global product strategies.
"The new, integrated organization will serve as an important tool in executing our more focused product strategies. In order to provide our customers with the best solutions and service, and to speed up development projects and our ability to deliver, we need a leaner and more agile organization that works 100% with consistent global strategies, and thus benefits from all the knowledge and expertise available in the company globally," explains Lars Frederiksen, CEO at Chr. Hansen.
The approximately 30 positions, which are now unnecessary, out of the current 540 within the US organization, constitute primarily back-office and support functions. Positions affected by the restructuring in the US organization were decided upon for economic and operational reasons consistent with the new organization.
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.